Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib [Phase 3]
Phase 3 rollover study of Olaparib for patients who have completed a prior oncology trial is active but not recruiting. The trial is sponsor…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study of PF-07248144 in Advanced or Metastatic Solid Tumors [Phase 2]
Pfizer is conducting a Phase 2 study of PF-07248144 in locally advanced or metastatic ER+ HER2- breast cancer, locally advanced or metastati…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) [Phase 1]
Phase Ib study investigating alpelisib in combination with pembrolizumab in metastatic breast cancer or melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Breast Cancer Evolution During Neoadjuvant Systemic Therapy
Update on a breast cancer neoadjuvant systemic therapy trial, currently recruiting and covering ER-positive, HER2-positive, and triple-negat…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study [NA]
A randomized, self-controlled study protocol comparing instrument-assisted constant-speed injection to manual injection for large-volume sub…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer [NA]
A clinical trial investigating prehabilitation and comprehensive follow-up in women with breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF [Phase 1]
Phase 1 study to evaluate serial PET/CT imaging with the novel radiotracer [18F] Fluorthanatrace for cancer imaging; currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the dose of Zongertinib used alone or with other therapies in HER2-positive metastatic cancers, including breas…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients [Phase 1]
Phase 1 trial evaluating 18F-Fluoroazomycin Arabinoside PET-CT for diagnosing solid tumors, including breast and colorectal cancers, with ac…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of XB010 in Subjects With Solid Tumors [Phase 1]
A Phase 1 trial evaluating XB010 in locally advanced or metastatic solid tumors is currently recruiting across multiple indications.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Selumetinib and Olaparib in Solid Tumors [Phase 1]
Phase 1 trial evaluating the combination of selumetinib and olaparib in various solid tumors; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.
A real-world study evaluating patient outcomes and experiences with ribociclib in breast cancer is currently recruiting, sponsored by Novart…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation [Phase 1]
NT-175 is being studied in a Phase 1 trial enrolling adults with unresectable, advanced, or metastatic solid tumors positive for HLA-A*02:01…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer [NA]
A clinical trial evaluating the comparative performance of Molecular Breast Imaging (MBI) versus Magnetic Resonance Imaging (MRI) for identi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Multicomponent Prehabilitation in Older Adults With Breast Cancer [NA]
This entry notes a clinical trial recruiting older adults with breast cancer to test multicomponent prehabilitation. The study targets frail…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer [Phase 1]
Phase 1 pilot study evaluating the clinical utility of Pylarify PET-CT for detecting metastasis in pancreatic cancer, hepatocellular carcino…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer [NA]
A clinical trial update describes evaluating extended sentinel lymph node biopsy using a single tracer, methylene blue, after neoadjuvant th…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer [Phase 2]
This Phase II randomized multicenter trial (SAPPHIRe-II) is evaluating shorter schedules of adjuvant regional nodal irradiation in breast ca…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer
A clinical trial update describing a Patient Relevant Outcomes Improvement Program in high-risk HR-positive/HER2-negative early breast cance…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
Clinical trial update describing an infertility survey for reproductive-age women with breast cancer and gynecologic cancers; the study is c…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
A bidirectional cohort study to evaluate prophylactic resection surgery in individuals at moderate-to-high risk for hereditary ovarian cance…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
This study aims to identify markers of resistance to therapy in HER2-positive breast cancer by analyzing tumor microenvironment spatial inte…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors [Phase 1]
This is a Phase 1 trial evaluating BGB-43395 alone or in combination for advanced breast cancer and other solid tumors. Recruitment is ongoi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluates carboplatin and paclitaxel with or without panitumumab in invasive triple-negative breast cancer. The stu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. [Phase 2]
This is a Phase 2 exploratory neoadjuvant trial evaluating SHR-A1811 in combination with Pertuzumab for HER2-positive breast cancer; the stu…